Form 4: Molina Healthcare Director Barbara Brasier Receives Equity Grant Valued at $55,000

Molina Healthcare, Inc. Director Barbara L. Brasier acquired 180 shares of common stock on July 1, 2025, as part of her director compensation under the company's 2025 Equity Incentive Plan.

Summary

• Molina Healthcare, Inc. (MOH) Director Barbara L. Brasier reported the acquisition of 180 shares of common stock.
• The transaction occurred on July 1, 2025, with a per-share price of $306.29.
• The acquisition is a grant of stock under the Issuer's 2025 Equity Incentive Plan, compensating for services as a Director.
• The annual equity award for each director is set at $220,000, with $55,000 granted quarterly.
• The number of shares granted (180) was determined by dividing the quarterly award value ($55,000) by the closing stock price on the grant date ($306.29).
• Following this transaction, Barbara L. Brasier beneficially owns a total of 4,574 shares of Molina Healthcare, Inc. common stock.
• The filing was signed by Jeff D. Barlow, acting as power of attorney for Barbara L. Brasier, on July 2, 2025.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates routine, structured director compensation that aligns interests with shareholders, without any negative surprises or operational issues.

Positives

• The equity grant aligns the financial interests of Director Barbara L. Brasier with those of Molina Healthcare shareholders, promoting long-term value creation.
• The grant is part of a pre-established 2025 Equity Incentive Plan, indicating a structured and transparent approach to director compensation.

Negatives

• The issuance of new shares, even for compensation, can result in minor dilution for existing shareholders, though the impact from this specific grant of 180 shares is negligible.

Risks

• The value of the compensation received by the director is directly tied to the future performance of Molina Healthcare's stock price, exposing the director to market risk.

Future Outlook

The filing indicates that the equity grant is part of an ongoing quarterly compensation structure for directors under the 2025 Equity Incentive Plan, suggesting similar grants are expected in future quarters.

Management Comments

• The grant of stock was made under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day.

Industry Context

This transaction reflects a standard practice within the healthcare industry and publicly traded companies generally, where non-employee directors receive a portion of their compensation in the form of equity to align their interests with long-term shareholder value.

Comparison to Industry Standards

• Director equity compensation, such as the grant of shares under an incentive plan, is a common and widely accepted practice across publicly traded companies, including those in the healthcare sector like Molina Healthcare.
• While specific compensation amounts vary by company size, industry, and individual director responsibilities, the structure of granting equity to align director interests with shareholder returns is a global benchmark for corporate governance.
• Comparable companies in the managed healthcare sector, such as Centene Corporation (CNC), Anthem, Inc. (now Elevance Health, ELV), and UnitedHealth Group (UNH), also utilize equity-based compensation for their non-employee directors to foster long-term commitment and performance alignment.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Director Barbara L. Brasier as compensation for her services constitutes a related party transaction, which is a standard practice for director remuneration.

Stakeholder Impact

• Shareholders: Minor dilution from the issuance of new shares, but also benefit from increased alignment of director interests with long-term company performance.
• Director (Barbara L. Brasier): Receives compensation for services, with the value of that compensation directly tied to the company's stock performance.

Next Steps

• Future quarterly equity grants to directors are expected to continue under the 2025 Equity Incentive Plan, based on the established annual award value and prevailing stock prices.

Key Dates

Keywords

Molina Healthcare, MOH, SEC Form 4, Insider Trading, Director Compensation, Equity Grant, Stock Acquisition, Beneficial Ownership, Healthcare Sector, Corporate Governance